Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Inhibits FIH-1 Expression to Promote Tumor Angiogenesis in HBV-Related Hepatocellular Carcinoma

References

• Morse MA, Sun W, Kim R., et al. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res. 2019;25(3):912–920. doi:10.1158/1078-0432.CCR-18-1254
   PubMed Web of Science ®Google Scholar
• Li H. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Rev Gastroenterol Hepatol. 2021;15(3):217–233. doi:10.1080/17474124.2021.1842732
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68(6):394–424. doi:10.3322/caac.21492
   Web of Science ®Google Scholar
• Reyes A, Duarte LF, Farias MA, et al. Impact of hypoxia over human viral infections and key cellular processes. Int J Mol Sci. 2021;22:15. doi:10.3390/ijms22157954
   Web of Science ®Google Scholar
• Moon EJ, Jeong CH, Jeong JW, et al. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J. 2004;18(2):382–384. doi:10.1096/fj.03-0153fje
   PubMedGoogle Scholar
• Yoo YG, Na TY, Seo HW, et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene. 2008;27(24):3405–3413. doi:10.1038/sj.onc.1211000
   PubMed Web of Science ®Google Scholar
• Wu SX, Ye SS, Hong YX, et al. Hepatitis B virus small envelope protein promotes hepatocellular carcinoma angiogenesis via endoplasmic reticulum stress signaling to upregulate the expression of vascular endothelial growth factor A. J Virol. 2022;96(4): e0197521. doi:10.1128/jvi.01975-21
   PubMed Web of Science ®Google Scholar
• Yang X, Li H, Sun H, et al. Hepatitis B virus-encoded microRNA controls viral replication. J Virol. 2017;91(10). doi:10.1128/JVI.01919-16
   Web of Science ®Google Scholar
• Gan W, Chen X, Wu Z, et al. The relationship between serum exosome HBV-miR-3 and current virological markers and its dynamics in chronic hepatitis B patients on antiviral treatment. Ann Translat Med. 2022;10(10):536. doi:10.21037/atm-22-2119
   PubMed Web of Science ®Google Scholar
• Zhao X, Sun L, Mu T, et al. An HBV-encoded miRNA activates innate immunity to restrict HBV replication. J Mol Cell Bio. 2020;12(4):263–276. doi:10.1093/jmcb/mjz104
   PubMed Web of Science ®Google Scholar
• Chavalit T, Nimsamer P, Sirivassanametha K, et al. Hepatitis B virus-encoded microRNA (HBV-miR-3) regulates host gene ppm1a related to hepatocellular carcinoma. MicroRNA. 2020;9(3):232–239. doi:10.2174/2211536608666191104105334
   PubMedGoogle Scholar
• Tang J, Xiao X, Jiang Y, et al. miR-3 encoded by hepatitis b virus downregulates PTEN protein expression and promotes cell proliferation. J Hepatocell Carcinoma. 2020;7:257–269. doi:10.2147/JHC.S271091
   PubMed Web of Science ®Google Scholar
• Volkova YL, Pickel C, Jucht AE, Wenger RH, Scholz CC. The asparagine hydroxylase fih: a unique oxygen sensor. Antioxid Redox Signaling. 2022;37(13–15):913–935. doi:10.1089/ars.2022.0003
   PubMed Web of Science ®Google Scholar
• Chen T, Ren Z, Ye LC, et al. Factor inhibiting HIF1alpha (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1alpha pathway. Cancer Biol Ther. 2015;16(2):244–252. doi:10.1080/15384047.2014.1002346
   PubMed Web of Science ®Google Scholar
• Chen T, Yao LQ, Shi Q, et al. MicroRNA-31 contributes to colorectal cancer development by targeting factor inhibiting HIF-1alpha (FIH-1). Cancer Biol Ther. 2014;15(5):516–523. doi:10.4161/cbt.28017
   PubMed Web of Science ®Google Scholar
• Otani Y, Yoo JY, Chao S, et al. Oncolytic HSV-infected glioma cells activate notch in adjacent tumor cells sensitizing tumors to gamma secretase inhibition. Clin Cancer Res. 2020;26(10):2381–2392. doi:10.1158/1078-0432.CCR-19-3420
   PubMed Web of Science ®Google Scholar
• Liu QY, Gao LY, Xu L, et al. CASC2 inhibits the growth, migration, and invasion of thyroid cancer cells through sponging miR-18a-5p/FIH1 axis. Kaohsiung J Med Sci. 2021;37(4):268–275. doi:10.1002/kjm2.12331
   PubMed Web of Science ®Google Scholar
• Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014;124(25):3748–3757. doi:10.1182/blood-2014-05-576116
   PubMed Web of Science ®Google Scholar
• Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc. 2010;5(4):628–635. doi:10.1038/nprot.2010.6
   PubMed Web of Science ®Google Scholar
• Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA. 1987;84(4):1005–1009. doi:10.1073/pnas.84.4.1005
   PubMed Web of Science ®Google Scholar
• Shirabe K, Mano Y, Muto J, et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today. 2012;42(1):1–7. doi:10.1007/s00595-011-0058-8
   PubMed Web of Science ®Google Scholar
• Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of hepatocellular carcinoma in the Asia-pacific region. Gut Liver. 2016;10(3):332–339. doi:10.5009/gnl15257
   PubMed Web of Science ®Google Scholar
• Larsson SB, Tripodi G, Raimondo G, et al. Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. J med virol. 2018;90(10):1568–1575. doi:10.1002/jmv.25227
   PubMed Web of Science ®Google Scholar
• Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1 Suppl): S84–S101. doi:10.1016/j.jhep.2016.02.021
   PubMed Web of Science ®Google Scholar
• Wang ML, Wu DB, Tao YC, et al. The truncated mutant HBsAg expression increases the tumorigenesis of hepatitis B virus by regulating TGF-beta/smad signaling pathway. Virol J. 2018;15(1):61. doi:10.1186/s12985-018-0972-0
   PubMedGoogle Scholar
• O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402. doi:10.3389/fendo.2018.00402
   PubMed Web of Science ®Google Scholar
• Grundhoff A, Sullivan CS. Virus-encoded microRNAs. Virology. 2011;411(2):325–343. doi:10.1016/j.virol.2011.01.002
   PubMed Web of Science ®Google Scholar
• Dong M, Chen JN, Huang JT, Gong LP, Shao CK. The roles of EBV-encoded microRNAs in EBV-associated tumors. Crit Rev Oncol/Hematol. 2019;135:30–38. doi:10.1016/j.critrevonc.2019.01.014
   PubMed Web of Science ®Google Scholar
• Hansen A, Henderson S, Lagos D, et al. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev. 2010;24(2):195–205. doi:10.1101/gad.553410
   PubMed Web of Science ®Google Scholar
• Zhang S, Amahong K, Sun X, et al. The miRNA: a small but powerful RNA for COVID-19. Briefings Bioinf. 2021;22(2):1137–1149. doi:10.1093/bib/bbab062
   PubMed Web of Science ®Google Scholar
• Loukachov V, van Dort KA, Jansen L, Reesink HW, Kootstra NA. Identification of a novel HBV encoded miRNA using next generation sequencing. Viruses. 2022;14:6. doi:10.3390/v14061223
   Web of Science ®Google Scholar
• Moawad AW, Szklaruk J, Lall C, et al. Angiogenesis in hepatocellular carcinoma; pathophysiology, targeted therapy, and role of imaging. J Hepatocell Carcinoma. 2020;7:77–89. doi:10.2147/JHC.S224471
   PubMed Web of Science ®Google Scholar
• Peet D, Linke S. Regulation of HIF: asparaginyl hydroxylation. Novartis Found Symp. 2006;272:37–49.
   PubMedGoogle Scholar
• Cuninghame S, Jackson R, Zehbe I. Hypoxia-inducible factor 1 and its role in viral carcinogenesis. Virology. 2014;456:370–83.
   PubMed Web of Science ®Google Scholar
• Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000;14(1):34–44. doi:10.1101/gad.14.1.34
   PubMed Web of Science ®Google Scholar
• Bodily JM, Mehta KP, Laimins LA. Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 2011;71(3):1187–1195. doi:10.1158/0008-5472.CAN-10-2626
   PubMed Web of Science ®Google Scholar
• Darekar S, Georgiou K, Yurchenko M, et al. Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS One. 2012;7(7): e42072. doi:10.1371/journal.pone.0042072
   PubMed Web of Science ®Google Scholar
• Shin YC, Joo CH, Gack MU, Lee HR, Jung JU. Kaposi’s sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression. Cancer Res. 2008;68(6):1751–1759. doi:10.1158/0008-5472.CAN-07-2766
   PubMed Web of Science ®Google Scholar
• Sanz-Cameno P, Martin-Vilchez S, Lara-Pezzi E, et al. Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein. Am J Pathol. 2006;169(4):1215–1222. doi:10.2353/ajpath.2006.051246
   PubMed Web of Science ®Google Scholar
• Yen CJ, Lin YJ, Yen CS, et al. Hepatitis B virus X protein upregulates mTOR signaling through IKKbeta to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One. 2012;7(7): e41931. doi:10.1371/journal.pone.0041931
   PubMed Web of Science ®Google Scholar
• Yang JC, Teng CF, Wu HC, et al. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology. 2009;49(6):1962–1971. doi:10.1002/hep.22889
   PubMed Web of Science ®Google Scholar
• Rani S, Roy S, Singh M, Kaithwas G. Regulation of transactivation at C-TAD domain of HIF-1alpha by Factor-Inhibiting HIF-1alpha (FIH-1): a potential target for therapeutic intervention in cancer. Oxid Med Cell Longev. 2022;2022:2407223. doi:10.1155/2022/2407223
   PubMed Web of Science ®Google Scholar
• Wu Z, Cheng H, Liu J, et al. The oncogenic and diagnostic potential of stanniocalcin 2 in hepatocellular carcinoma. J Hepatocell Carcinoma. 2022;9:141–155. doi:10.2147/JHC.S351882
   PubMed Web of Science ®Google Scholar
• Cao L, Cheng H, Jiang Q, Li H, Wu Z. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging. 2020;12(5):4573–4591. doi:10.18632/aging.102913
   PubMedGoogle Scholar
• Cheng H, Fan X, Ye E, et al. Dual tumor microenvironment remodeling by glucose-contained radical copolymer for MRI-guided photoimmunotherapy. Adv Mater. 2022;34(25): e2107674. doi:10.1002/adma.202107674
   PubMed Web of Science ®Google Scholar